The Os03g0405900 gene encodes a probable nucleoredoxin 1-2, a redox-regulating protein involved in maintaining cellular oxidative balance. Nucleoredoxins are crucial for mitigating oxidative stress during phosphorus (P) deprivation, a common abiotic stress in plants. Under low P conditions, rice roots upregulate nucleoredoxins to protect cellular components from reactive oxygen species (ROS) while enhancing phosphate uptake efficiency .
Molecular weight: Predicted ~22 kDa (exact weight depends on post-translational modifications) .
Functional domains: Contains a thioredoxin-like fold critical for redox activity .
This antibody is primarily utilized in proteomic and molecular studies to:
Detect nucleoredoxin expression in rice tissues under varying phosphorus conditions .
Localize nucleoredoxin in root cells using immunohistochemistry .
| Protein ID | Description | Fold Change (RLP/RCK) | p Value |
|---|---|---|---|
| Os03g0405900 | Probable nucleoredoxin 1-2 | 2.22 | 0.0006 |
RLP/RCK: Ratio of root tissue under low phosphorus (RLP) vs. control (RCK).
Antibody specificity for Os03g0405900 is validated using:
Immunoprecipitation (IP) followed by mass spectrometry to verify protein identity .
Cross-reactivity tests against homologous proteins (e.g., nucleoredoxin 1-1, Os03g0405500) .
Recent studies highlight that ~50–75% of commercial antibodies for plant proteins lack sufficient validation, emphasizing the need for rigorous testing . For example, YCharOS initiatives demonstrated that recombinant antibodies outperform polyclonal and monoclonal variants in specificity .
Os03g0405900 is upregulated 2.2-fold under phosphorus-deficient conditions, correlating with enhanced ROS scavenging and improved root architecture . Its expression is co-regulated with phosphate transporters (e.g., PHT1-8) and phosphatases .
Nucleoredoxin 1-2 interacts with:
Antibody reliability: Only 20–40% of commercially available antibodies for plant proteins are validated for specific applications .
Scalability: High-throughput validation pipelines (e.g., YCharOS) are needed to improve reagent reproducibility .
Therapeutic potential: While primarily used in research, plant-derived antibodies like Os03g0405900 could inspire bioengineered crops with stress resilience .
Western Blot: 1:200–1:1000.
Immunoprecipitation: 0.5–4.0 µg per 1–3 mg lysate.
Controls: Use rabbit IgG isotype controls (e.g., Proteintech 30000-0-AP) to minimize false positives .
Os03g0405900 (MSU ID: LOC_Os03g29240) encodes a probable nucleoredoxin 1-2 protein in rice (Oryza sativa). This protein has shown significant upregulation (ratio of 2.22151414, p-value 0.0006) under phosphorus deficiency conditions, making it an important marker for phosphorus stress response . Nucleoredoxins are thioredoxin-related proteins involved in redox regulation and signaling pathways. The protein's association with the quantitative trait locus (QTL) qTDW-2 indicates its potential role in phosphorus use efficiency and stress adaptation mechanisms . Antibodies targeting Os03g0405900 are valuable tools for investigating phosphorus deficiency responses and redox signaling networks in plants.
Proteomic analysis reveals that Os03g0405900 (Probable nucleoredoxin 1-2) shows a 2.22-fold upregulation (p=0.0006) under low phosphorus conditions, while its related family member Os03g0405500 (Probable nucleoredoxin 1-1) shows a 1.82-fold increase (p=0.017644) . This differential expression pattern suggests distinct functional roles for these nucleoredoxin variants in phosphorus stress response. The table below highlights the comparison:
| RAP (Os ID) | MSU (LOC_Os ID) | Description | Ratio (RLP/RCK) | p Value |
|---|---|---|---|---|
| Os03g0405900 | LOC_Os03g29240 | Probable nucleoredoxin 1-2 | 2.22151414 | 0.0006 |
| Os03g0405500 | LOC_Os03g29190 | Probable nucleoredoxin 1-1 | 1.822377514 | 0.017644 |
When developing antibodies against either variant, researchers should carefully consider epitope selection to ensure specificity between these closely related proteins.
For effective Os03g0405900 protein detection, several techniques can be employed depending on research objectives:
Western blotting: Optimal for quantitative analysis of protein expression levels across different treatments or tissues. Use 10-12% SDS-PAGE gels with reducing conditions. Transfer to PVDF membranes typically yields better results than nitrocellulose for plant proteins.
Immunoprecipitation: Valuable for studying protein-protein interactions. Cross-linking with formaldehyde before extraction can preserve transient interactions.
Immunohistochemistry/Immunofluorescence: For localizing Os03g0405900 within specific tissues or cellular compartments. Fixation with 4% paraformaldehyde is generally effective for plant tissues.
ELISA: Suitable for high-throughput quantitative analysis across multiple samples. Consider using a sandwich ELISA approach with a capture antibody against Os03g0405900 and a detection antibody against a fusion tag if using recombinant proteins.
Similar to p40 antibody methodology, validation should include positive controls using tissues known to express the target protein and negative controls with tissues where expression is absent or knockdown models .
Developing highly specific antibodies against Os03g0405900 (nucleoredoxin 1-2) requires careful epitope selection to differentiate it from the closely related Os03g0405500 (nucleoredoxin 1-1). The following methodological approach is recommended:
Sequence alignment analysis: Identify unique regions in Os03g0405900 that differ from Os03g0405500. Focus on hydrophilic, surface-exposed regions that are likely accessible to antibodies.
Epitope selection criteria:
Choose peptide sequences 12-20 amino acids in length
Select regions with <60% sequence identity to Os03g0405500
Avoid transmembrane domains and signal peptides
Prioritize regions with high antigenicity scores
Validation strategy:
Test against recombinant Os03g0405900 and Os03g0405500 proteins
Perform competitive binding assays with the immunizing peptide
Include knockout/knockdown tissues as negative controls
Conduct Western blots with tissues expressing different levels of both proteins
Employ immunoprecipitation followed by mass spectrometry to confirm specificity
Similar to the approach used with p40 antibody development, where epitope selection focused on unique regions not shared with p63, specificity testing should be rigorous to ensure the antibody recognizes only the intended target .
For studying Os03g0405900 protein interactions under phosphorus stress conditions, consider the following optimized immunoprecipitation protocol:
Plant material preparation:
Extraction buffer optimization:
Base buffer: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 0.1% Triton X-100
Include phosphatase inhibitors (10 mM NaF, 1 mM Na₃VO₄, 5 mM β-glycerophosphate)
Add protease inhibitor cocktail
Consider including 10 mM DTT to maintain redox-sensitive interactions
For crosslinking studies, use 1% formaldehyde in PBS for 10 minutes
Immunoprecipitation procedure:
Pre-clear lysate with Protein A/G beads
Incubate with Os03g0405900 antibody (5-10 μg) overnight at 4°C
Add pre-washed Protein A/G beads for 2-3 hours
Wash extensively (at least 5 times) with decreasing salt concentrations
Elute with 2X SDS sample buffer or acidic glycine buffer
Controls and validation:
Include IgG control immunoprecipitations
Use tissues with different Os03g0405900 expression levels (e.g., normal vs. P-deficient)
Consider reverse immunoprecipitation with antibodies against suspected interacting partners
Validate interactions using alternative methods (yeast two-hybrid, BiFC)
Analysis of immunoprecipitated complexes:
Western blot for known/suspected partners
Mass spectrometry for unbiased identification of all interacting proteins
Compare interactome under normal vs. low phosphorus conditions
Integrating antibody-based detection with transcriptomic data enables robust functional analysis of Os03g0405900. The following methodological framework is recommended:
Correlation analysis workflow:
Establish timeline experiments where both protein and RNA are extracted from the same samples
Quantify Os03g0405900 protein levels via Western blot or ELISA
Measure Os03g0405900 mRNA expression via qRT-PCR or RNA-seq
Calculate Pearson or Spearman correlation coefficients between protein and mRNA levels
Create time-lag correlation analyses to detect delayed protein expression
Multi-omics integration approach:
Create overlapping datasets using consistent experimental conditions
Normalize protein expression data (from antibody-based assays) and transcript data
Apply statistical methods like ANOVA or mixed linear models to identify consistent patterns
Consider using multivariate analysis methods (PCA, PLS-DA) to identify co-regulated genes/proteins
Discrepancy analysis:
Identify conditions where transcript and protein levels show discordance
Investigate potential post-transcriptional regulation mechanisms
Examine protein stability using cycloheximide chase assays and the Os03g0405900 antibody
Analyze phosphorylation or other post-translational modifications that may affect protein stability
Pathway analysis enhancement:
Use antibody-based co-immunoprecipitation to identify protein interaction networks
Compare interaction networks with co-expression networks from transcriptomic data
Identify regulatory hubs that may affect both transcript and protein levels
In the referenced phosphorus stress study, integrating the proteomic data showing 2.22-fold protein upregulation with transcriptomic data provided complementary insights into the role of Os03g0405900 in stress response mechanisms .
Validating a new Os03g0405900 antibody requires a comprehensive set of controls to ensure specificity and reliability:
Essential positive controls:
Critical negative controls:
Os03g0405900 knockout/knockdown plants
Pre-immune serum at equivalent concentration
Competitive inhibition with immunizing peptide
Non-expressing tissues or species
Secondary antibody only
Specificity controls:
Recombinant Os03g0405500 (nucleoredoxin 1-1) to test for cross-reactivity
Other related thioredoxin family proteins
Tissues from plants expressing varying levels of Os03g0405900
Application-specific controls:
For Western blotting: Molecular weight markers, loading controls
For immunoprecipitation: IgG control, input sample
For immunohistochemistry: Peptide competition, isotype control
For ELISA: Standard curve with recombinant protein
Technical validation:
Multiple antibody concentrations/dilutions
Different detection methods (fluorescent vs. chromogenic)
Batch testing to ensure reproducibility
This approach parallels the rigorous validation used in p40 antibody development, where specificity testing against potential cross-reactive proteins was crucial for reliable results .
When encountering weak or inconsistent signals with Os03g0405900 antibodies in Western blotting, follow this systematic troubleshooting approach:
Sample preparation optimization:
Buffer composition: Try different extraction buffers containing various detergents (RIPA, NP-40, Triton X-100)
Protease inhibitors: Ensure complete protease inhibitor cocktail is fresh and active
Reducing agents: Test different concentrations of β-mercaptoethanol or DTT (5-100 mM)
Sample denaturation: Vary heating time (5-10 minutes) and temperature (70-100°C)
Protein concentration: Load increasing amounts (10-100 μg) to determine optimal loading
Electrophoresis and transfer parameters:
Gel percentage: Optimize acrylamide percentage based on protein size
Transfer conditions: Test wet transfer vs. semi-dry, vary buffer composition and time
Membrane selection: Compare PVDF and nitrocellulose membranes
Transfer efficiency: Verify with reversible protein stains (Ponceau S)
Antibody optimization:
Concentration: Test serial dilutions (1:500 to 1:10,000)
Incubation conditions: Vary temperature (4°C, room temperature) and time (1 hour to overnight)
Blocking agents: Compare different blockers (5% milk, 5% BSA, commercial blockers)
Secondary antibody: Optimize dilution and consider enzyme-conjugated vs. fluorescent detection
Signal enhancement strategies:
Extended exposure times
More sensitive substrates for HRP (Super Signal West Femto vs. ECL)
Signal amplification systems (biotin-streptavidin)
Concentration of protein by immunoprecipitation before Western blotting
Consider biological variables:
Developmental stage: Os03g0405900 expression varies with plant development
Stress conditions: Ensure phosphorus deficiency is sufficient to induce upregulation
Tissue selection: Choose tissues known to express Os03g0405900
If persistent problems occur, consider epitope retrieval techniques or alternative antibodies targeting different epitopes of Os03g0405900.
Designing effective immunolocalization studies for Os03g0405900 requires careful consideration of several methodological aspects:
Tissue preparation protocols:
Fixation: Compare 4% paraformaldehyde, glutaraldehyde, or combination fixatives
Embedding media: Paraffin for light microscopy vs. resin for higher resolution
Section thickness: Optimize between 5-10 μm for immunofluorescence, 70-100 nm for immunogold
Antigen retrieval: Test heat-induced (citrate buffer) and enzymatic methods
Tissue permeabilization: Optimize detergent concentration (0.1-0.5% Triton X-100) and time
Antibody application strategy:
Primary antibody dilution: Start with 1:100-1:500 and adjust as needed
Incubation parameters: Compare 1-2 hours at room temperature vs. overnight at 4°C
Washing protocol: Determine optimal buffer composition and washing times
Secondary antibody selection: Choose fluorophores appropriate for tissue autofluorescence
Signal amplification: Consider tyramide signal amplification for low-abundance proteins
Essential controls:
Technical considerations:
Counter-staining: DAPI for nuclei, cell wall stains for structural context
Mounting media: Anti-fade reagents to prevent photobleaching
Microscope settings: Consistent exposure times and gain settings
Z-stack acquisition: For 3D reconstruction of protein localization
Quantification methods: Fluorescence intensity measurement protocols
Biological considerations:
Developmental stages: Compare tissues at different developmental points
Stress progression: Examine localization changes during onset and prolonged P deficiency
Diurnal changes: Consider potential temporal variation in protein localization
When optimizing these protocols, begin with tissues known to express high levels of Os03g0405900, such as tissues under phosphorus stress conditions as identified in the proteomic study .
For rigorous quantification and analysis of Western blot data for Os03g0405900 under varying phosphorus conditions, implement the following methodological approach:
Experimental design for quantitative Western blotting:
Include a concentration gradient of recombinant Os03g0405900 to create a standard curve
Process all experimental samples simultaneously to minimize technical variation
Include at least 3-4 biological replicates per condition
Load equal amounts of total protein (verified by protein assay)
Include multiple loading controls (actin, GAPDH, and total protein stain)
Image acquisition protocol:
Capture images within the linear dynamic range of the detection system
Use identical exposure settings for all experimental samples
Include oversaturation alerts during image acquisition
For fluorescent detection, capture multiple channels simultaneously
Quantification methodology:
Use software that supports background subtraction (ImageJ, Image Lab, etc.)
Define measurement regions consistently across all samples
Normalize Os03g0405900 signal to loading controls
Calculate relative fold changes compared to control conditions
For absolute quantification, use the recombinant protein standard curve
Statistical analysis:
Test for normal distribution of data (Shapiro-Wilk test)
Apply appropriate statistical tests (t-test for two conditions, ANOVA for multiple conditions)
Use post-hoc tests (Tukey's HSD) for pairwise comparisons
Report p-values and confidence intervals
Consider regression analysis for time-course or dose-response experiments
Data presentation:
Present quantification with error bars representing standard deviation or SEM
Include representative blot images
Indicate statistical significance levels
Create correlation plots between protein levels and relevant physiological parameters
When interpreting results, compare observed fold changes with the 2.22-fold upregulation (p=0.0006) reported in the proteomic study as a reference point for validation.
When faced with discrepancies between antibody-based protein detection and mRNA expression data for Os03g0405900, adopt the following systematic interpretation framework:
Validation of both methodologies:
Confirm antibody specificity through Western blot with recombinant protein and knockout controls
Verify PCR primer specificity through sequencing of amplification products
Check for technical issues in both protein and RNA extraction protocols
Include positive controls for both techniques
Biological explanations for discrepancies:
Temporal delay: Transcription often precedes protein accumulation (6-8 hour lag typically)
Post-transcriptional regulation: miRNAs may inhibit translation without affecting mRNA levels
Protein stability: Differences in protein turnover rates affecting steady-state levels
Translational efficiency: Codon bias or secondary structures in mRNA affecting translation rate
Post-translational modifications: Changes affecting antibody recognition without altering protein abundance
Analytical approach to resolve contradictions:
Time-course experiments to detect temporal shifts between mRNA and protein peaks
Polysome profiling to assess translational efficiency of Os03g0405900 mRNA
Protein stability assays using cycloheximide or pulse-chase experiments
Analysis of phosphorylation status or other post-translational modifications
Subcellular fractionation to check for compartmentalization changes
Integration strategies:
Create a combined scoring system weighting both protein and mRNA data
Consider pathway-level analysis rather than focusing solely on Os03g0405900
Examine related proteins (e.g., Os03g0405500, nucleoredoxin 1-1) for similar patterns
Apply mathematical modeling to predict expected protein levels from mRNA data
Reporting recommendations:
Present both datasets with clear acknowledgment of discrepancies
Provide multiple working hypotheses to explain contradictions
Suggest follow-up experiments to resolve conflicts
Consider the biological significance of the discrepancy itself as a finding
Differential regulation between transcript and protein levels may have functional significance in stress response mechanisms, as observed in various phosphorus-responsive proteins .
For rigorous comparison of Os03g0405900 antibody specificity across different experimental conditions, implement the following methodological framework:
Cross-platform validation strategy:
Compare multiple detection methods (Western blot, ELISA, immunoprecipitation)
Test antibody performance in native vs. denaturing conditions
Evaluate antibody in both reducing and non-reducing environments
Assess epitope accessibility in fixed vs. fresh tissues
Antibody performance metrics:
Signal-to-noise ratio calculation under each condition
Limit of detection determination using purified protein standards
Dynamic range assessment using dilution series
Coefficient of variation across technical and biological replicates
Cross-reactivity profile with related proteins (especially Os03g0405500)
Experimental validation designs:
Peptide competition assays under each condition
Knockout/knockdown validation across all experimental setups
Epitope-tagged recombinant protein expression as positive control
Immunodepletion studies to confirm specificity
Mass spectrometry validation of immunoprecipitated proteins
Comparative analysis between conditions:
Create a scoring matrix evaluating antibody performance across parameters
Use statistical approaches (ANOVA) to identify significant differences
Generate ROC curves to assess diagnostic value under each condition
Calculate specificity and sensitivity metrics for each experimental setup
Standard operating procedure development:
Document optimal conditions for each application
Create decision trees for troubleshooting
Establish quality control thresholds for acceptable performance
Develop standard curves for quantitative applications
This approach parallels the rigorous validation methodology used for diagnostic antibodies like p40 , where specificity was systematically tested against potential cross-reactive proteins across multiple sample types and detection methods.
Os03g0405900 antibodies can be strategically employed to investigate this protein's role in phosphorus stress response through the following methodological approaches:
Temporal and spatial expression profiling:
Time-course analysis following phosphorus deprivation (hours to days)
Tissue-specific accumulation patterns using immunohistochemistry
Subcellular localization changes under stress using immunofluorescence
Quantitative Western blot analysis across diverse rice cultivars with varying P-efficiency
Protein interaction network mapping:
Co-immunoprecipitation followed by mass spectrometry to identify interacting partners
Proximity labeling (BioID) using Os03g0405900 fusion proteins
Yeast two-hybrid validation of potential interactions
In situ protein-protein interaction studies using BiFC or FRET
Comparative interactome analysis between normal and P-deficient conditions
Post-translational modification analysis:
Phosphorylation state monitoring using phospho-specific antibodies
Redox state analysis using redox proteomics approaches
Ubiquitination patterns using co-immunoprecipitation with ubiquitin antibodies
Stability assessment using cycloheximide chase assays
Functional studies:
Antibody-mediated inhibition in cellular extracts or permeabilized cells
Immunodepletion studies to assess enzymatic activity contributions
Correlation of protein levels with physiological parameters of P-efficiency
Analysis of protein-DNA interactions using ChIP if DNA-binding activity is suspected
Integration with QTL analysis:
Protein expression quantification in populations segregating for qTDW-2 QTL
Correlation of protein levels with phenotypic variation in P-efficiency traits
Development of protein-based markers for selection in breeding programs
The proteomic data showing significant upregulation (2.22-fold, p=0.0006) under phosphorus stress conditions provides a strong foundation for these investigations, particularly when combined with the protein's genetic association with the qTDW-2 QTL relevant to phosphorus use efficiency .
Emerging technologies offer promising opportunities to enhance antibody-based studies of Os03g0405900, particularly in understanding its role in phosphorus stress response:
Advanced imaging technologies:
Super-resolution microscopy (PALM, STED, SIM) for nanoscale localization
Expansion microscopy for enhanced spatial resolution in plant tissues
Light-sheet microscopy for rapid 3D imaging with minimal photodamage
Correlative light and electron microscopy (CLEM) for ultrastructural context
Label-free imaging methods to complement antibody-based detection
Single-cell and spatial technologies:
Single-cell proteomics to detect cell-type specific responses
Spatial transcriptomics combined with in situ antibody detection
Mass cytometry (CyTOF) for multiparameter protein profiling
Imaging mass spectrometry for spatial protein distribution
Digital spatial profiling for quantitative in situ protein measurement
Protein dynamics tools:
FRAP (Fluorescence Recovery After Photobleaching) for protein mobility studies
Optogenetic tools combined with antibody detection
Microfluidic approaches for real-time monitoring of protein responses
Live-cell imaging with nanobodies derived from conventional antibodies
CRISPR-mediated tagging for endogenous protein tracking
High-throughput antibody applications:
Microwestern arrays for parallel analysis of multiple conditions
Reverse phase protein arrays for large-scale screening
Antibody arrays for studying multiple phosphorus-responsive proteins simultaneously
Automated immunoprecipitation platforms for standardized interaction studies
Multiplex imaging with antibody barcoding techniques
Computational integration approaches:
Machine learning algorithms for antibody binding prediction
Network analysis tools for interpreting protein interaction data
Multi-omics data integration platforms
Structural modeling to predict antibody epitope accessibility
Systems biology approaches to position Os03g0405900 in stress response networks
Implementation of these technologies could significantly enhance our understanding of Os03g0405900's role in phosphorus stress response, particularly in relation to the 2.22-fold upregulation observed in proteomic studies and its association with the qTDW-2 QTL .